Publications in collaboration with researchers from Hospital Universitario Virgen del Rocío (13)

2021

  1. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

2019

  1. Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis

    Diabetes Research and Clinical Practice, Vol. 148, pp. 10-13

  2. Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors

    Revista Clinica Espanola, Vol. 219, Núm. 4, pp. 208-217

  3. GLP-1 and the renin–angiotensin–aldosterone system

    The Lancet Diabetes and Endocrinology

  4. In response to Yaribeygi et al. "Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"

    Journal of Cellular Physiology

  5. Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study

    Journal of Clinical Lipidology, Vol. 13, Núm. 6, pp. 989-996

  6. Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months

    Diabetes Research and Clinical Practice, Vol. 158

  7. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

    Atherosclerosis, Vol. 285, pp. 17-22

2018

  1. Reply to ‘Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes’ by Yoshimoto et al.

    Journal of Investigative Medicine

  2. Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?

    Medicina Clinica, Vol. 150, Núm. 1, pp. 33-38

  3. Use of degludec insulin in chronic complex patients

    European Journal of Internal Medicine

2017

  1. Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)

    Circulation, Vol. 135, Núm. 22, pp. 2133-2144

2016

  1. Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up

    Journal of the American College of Cardiology, Vol. 67, Núm. 11, pp. 1278-1285